CALA - Calithera Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue22,25425,955--
Cost of Revenue66,19543,11127,74823,748
Gross Profit-43,941-17,156-27,748-23,748
Operating Expenses
Research Development----
Selling General and Administrative13,34012,53010,5869,071
Non Recurring----
Total Operating Expenses79,53555,64138,33432,819
Operating Income or Loss-57,281-29,686-38,334-32,819
Income from Continuing Operations
Total Other Income/Expenses Net2,6521,860330175
Earnings Before Interest and Taxes-57,281-29,686-38,334-32,819
Interest Expense----
Income Before Tax-54,629-27,826-38,004-32,644
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-54,629-27,826-38,004-32,644
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-54,629-27,826-38,004-32,644
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-54,629-27,826-38,004-32,644